Last update December
Editorial Policies Adopted by
Scholarly Journals Published by Shahrekord University of Medical Sciences
of Herbmed Pharmacology has adopted the ICMJE
recommendations for authorship. According to the ICMJE recommendations the
authorship is based on the four criteria below:
contributions to the conception or design of the work, or the gathering,
analysis or interpretation of data.
2. Drafting the work or
revising it critically for important intellectual content.
3. Final approval of the
4. Agreement to be
accountable for all aspects of the work in ensuring that queries regarding the
accuracy or integrity of any parts of the work are appropriately investigated
In addition to being
accountable for the parts of the conducted work, an author should be able to
clearly recognize which co-authors are responsible for specific other parts of
the work. Furthermore, authors should have confidence in the integrity of their
co-authors’ contributions. All those designated as authors should meet all four
criteria of authorship, and all who meet the four criteria should be listed as
authors. Those who do not meet all four criteria should be listed in an
Acknowledgements section. Participation solely in the acquisition of funding,
the gathering of data, technical help, writing assistance, and general
supervision of the research group does not mean authorship. Financial and
material support should also be acknowledged. Please ensure that anyone
mentioned in the Acknowledgements has given permission to be listed.
A contributorship statement is necessary for
every manuscript submitted and should state authors’ contributions to the
planning, conduct, and reporting of the work.
Mention individuals who assisted in the project.
Report all sources of grant and other funding for the project or study,
including funds paid by contributors, institutions
and commercial sources. Consultancies and funds
directly paid to investigators must be listed, as well.
Any change in authorship (ie, order, addition,
and deletion) after initial submission must be approved by all authors. Authors
should determine the order of authorship among themselves. In addition, any
alterations must be clarified to the Editor/Editor-in-chief.
A competing interest exists when professional
decision on a primary interest (such as the validity of research) could be
influenced by a secondary interest (such as financial gain, employment,
consultancies, stock ownership, honoraria, etc). A competing interest is not
considered unethical per se but it should be declared and clearly expressed.
All authors must announce all competing interests in covering letter and in
“Competing Interests” section at the end of the manuscript (before the
references). Authors with no competing interests to report should state that
The policy of Journal of Herbmed Pharmacology is that none of
the editors should have any financial relationship with any biomedical company.
Ethical approval of
Journal of Herbmed Pharmacology follow the
Committee on Publication Ethics (COPE) and aim to adhere to its Best Practice
We seriously consider allegations of publication
misconduct, both before and after publication, and we reserve the right to inform
authors' employers, funders, or regulatory bodies if necessary. If we find
definite evidence of misconduct, we will take necessary measures to correct the
scientific record, including supplying a correction or retraction.
Authors are strongly recommended to know and
follow publication ethics, especially with regard to authorship, dual
submission, figure manipulation, competing interests, plagiarism, and
compliance with standards of research ethics. In cases of suspected misconduct,
we will follow COPE standards and practices and may refer to COPE forum if
Statement of Ethics Approval
Every research article submitted must include a
statement that the study has been approved for ethical considerations (or a
statement that it was not required and declare the reason), including the name
of the ethics committee(s) or institutional review board(s), the number/ID of
the approval(s), and a statement that participants offered informed consent
prior to participation. Even when a study has been approved by a research
ethics committee or institutional review board, editors may request authors for
more detailed information regarding the ethical considerations of the study.
Patient consent and confidentiality
Any article that includes personal medical
information about an identifiable living individual requires the patient’s
explicit consent before we publish it. We expect the patient to sign our
consent form, which requires the patient to have read the article.
If it is not possible to obtain informed consent
because the patient cannot be found then the work will be published only if the
identifying information is adequately anonymized. Anonymization means that no
one, including the patient, could identify the patient definitely.
If the patient has deceased, the authors should
obtain permission from a relative (for courtesy and medical ethics). If the
relatives cannot be accessed, we will balance the seriousness of the case and
the likelihood of identification as well as offence if identified in judging
whether we should publish without a relative’s consent.
Our policy on obtaining consent for publication
of patients’ pictures is a subdivision of our general policy regarding patient
confidentiality. If it is likely that a patient could be identified through a photograph,
any images or its accompanying text, the patient’s written consent to
publication is required by Journal of Herbmed Pharmacology.
Images, such as x rays, ultrasound images,
laparoscopic images, pathology slides, or images of undistinctive parts of the
body, can be used without consent if they are anonymized by eliminating any
identifying marks and do not contain text that could divulge the patient’s
identity through clinical or personal facts.
Research reporting guidelines
Authors are advised to apply the relevant
research reporting guidelines for the study type declared by the EQUATOR
Network, ensuring that you provide sufficient information for editors, peer
reviewers and readers to understand how the research was conducted and to judge
whether the findings are possibly reliable.
The key reporting guidelines are:
1. Randomised controlled
trials (RCTs): CONSORT guidelines
2. Systematic reviews and
meta-analyses: PRISMA guidelines and MOOSE guidelines
3. Observational studies in
epidemiology: STROBE guidelines and MOOSE guidelines
4. Diagnostic accuracy
studies: STARD guidelines
5. Quality improvement
studies: SQUIRE guidelines
Clinical trial registration
By ICMJE recommendations, a clinical trial is
defined as “any research project that prospectively assigns people or a group
of people to an intervention, with or without concurrent comparison or control
groups, to study the cause-and-effect relationship between a health-related
intervention and a health outcome”.
According to the ICMJE, Journal of Herbmed
Pharmacology will not have clinical trials considered for publication unless
they were registered prospectively before enrollment of any participants.
For consideration for publication, Journal of
Herbmed Pharmacology require registration of all trials in a public trials
registry that is acceptable to the ICMJE (any registry that is a primary
register of the WHO International Clinical Trials Registry Platform
www.who.int/ictrp /network/primary/en/index.html or in ClinicalTrials.gov,
which provides the data to the WHO ICTRP).
Journals published by Shahrekord University of
Medical Sciences use iThenticate software, which is a plagiarism detector that
verifies the content originality before publication. If plagiarism is
identified, COPE guidelines will be followed.
Plagiarism includes, but is not limited to:
1. Directly copying text
from other sources
2. Copying ideas, images,
or data from other sources
3. Reusing text from your
own previous publications
4. Using an idea from
another source with slightly modified language
If plagiarism is detected
throughout the peer review, the manuscript may be rejected. If plagiarism is
detected after publication, a correction or retraction of the paper is likely,
as appropriate. Moreover, authors' institutions are informed about plagiarism
detected either before or after publishing the work.
Peer review policy
Journal of Herbmed Pharmacology review all
manuscript submissions, internally or externally.
Original research articles authored by a member
of a journal’s editorial team are independently peer reviewed; an editor will
have no input or influence on the peer review process or publication decision
for their own article. Editorials and obituaries written by the journal’s
editor do not undergo external peer review.
Peer Review Procedures
submitted to Journal of Herbmed Pharmacology
are rigorously reviewed. This review consists of the following steps:
1. Initial submissions are
reviewed by internal staff to ensure following of policies of Journal of Herbmed Pharmacology, such as
ethical requirements for human and animal experimentation.
2. Submissions are then
assigned to an Editor for evaluation.
3. The Academic Editor
decides whether reviews from additional experts are needed to evaluate the
manuscript. The majority of submissions are evaluated by two external
reviewers, but it is up to the Editor to determine the number of reviews.
4. After evaluation, the
Editor chooses between the following decisions:
If the decision is Minor Revision or Major Revision, authors have
30 days to resubmit the revised manuscript. Authors may contact email
address if they require an extension.
Upon resubmission, the Editor may choose to send the manuscript
back to external reviewers, or may render a decision based on personal
It is the author’s
responsibility to secure all required permissions before publication.
Material from other sources
Any written or illustrative material that has
been or will be published elsewhere must be acknowledged and accompanied by the
written consent of the copyright owner (that may be the publisher rather than
the author). This also includes your own previously published material, if you
are not the copyright owner.
Reproducing material published by Journal of
Herbmed Pharmacology Materials
published by Journal of Herbmed Pharmacology may be reproduced fully or
partially in any medium or language only if the original material is cited
Journal of Herbmed Pharmacology is published
every three months (quarterly) in January, April, July and October each year.
Publication in Journal of
Herbmed Pharmacology is free of charge.
For advertising in a
periodical published by Shahrekord University of Medical Sciences, please
consult the Publications Office at www.skums.ac.ir.